Healthcare
Advisory
Belgium, United States
M&A Advisory
M&A Advisory Firm
Industry:
Healthcare
Location:
Belgium, United States
Year:
2018
Full Credential Description
UCB. Belgium, United States. Announced Date 20/04/2018. Closed Date 11/06/2018. Deal value: $370m. UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen. Industry: UCB is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines and solutions for people with severe diseases in immunology and neurology.
Measurable Results
$370.0M